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Introduction: Among heterocyclic anticancer compounds, quinoxalines and 
imidazolidine-2,4-dione are the most prominent since they constitute important 
classes of natural products and synthetic pharmaceuticals. In general, they are used 
as valuable intermediates and building blocks in pharmaceutical synthesis. 
Therefore, much attention has been paid to the synthesis of quinoxaline derivatives 
bearing imidazolidine-2,4-dione either by classic methods or by multicomponent 
reactions. 
 Methods and Results: The title compound was prepared through a three- step 
procedure. In the first step, equimolar amounts of D-glucose and o-
phenylenediamine were reacted with phenyl hydrazine in the presence of acetic acid, 
to form the pyrazolo[4,5-b]quinoxaline  derivative.  
The second step involved oxidation of the resulted compound by use of sodium 
metaperioddate.  
Finally, the related aldehyde was condensed by imidazolidine-2,4-dione to yield the 
corresponding 3-alkylidene pyrazolo[4,5-b]quinoxaline . 
Conclusions: 
The procedure applied in this study established a convenient method for the 
preparation of the title compounds. The process was straight forward and it used 
abundant and readily available staring materials. Due to its chemical structure, and 
in particular the presence of the quinioxaline ring, which is a commonly encountered 
motif in compounds of medicinal interest, the prepared product is expected to show 
anticancer activity. 
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